Aug 29, 2024 / 12:00AM GMT
Operator
Good morning, everybody, and welcome to the ImpediMed FY24 results presentation. With us this morning, we have Parmjot Bains, the Chief Executive Officer, and McGregor Grant, the Chief Financial Officer, who will take us through the presentation that was lodged with the ASX this morning and just a bit of housekeeping, today's webinar is being recorded, including the Q&A and we intend to launch this on the ImpediMed, which website and after the webinar has been completed.
(Operator Instructions) Handing over to Parmjot for the results presentation.
Parmjot Bains - ImpediMed Ltd - Interim Chief Executive Officer, Managing Director, Executive Director
Good morning. Welcome to our ImpediMed investor call for the fiscal year 2024 ending June 2024, and then ImpediMed, our mission really is to improve patient outcomes by setting the new standard of care and fluid and body composition management.
We achieved this for our bioimpedance spectroscopy technology to assess and monitor the fluid composition and tissue composition and patients. Our
Full Year 2024 ImpediMed Ltd Earnings Call Transcript
Aug 29, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers